35 results on '"Green, Caitlin"'
Search Results
2. Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone
- Author
-
Borris, Joshua B., Dowd-Green, Caitlin, Bowman, Lindsay A., Nesbit, Suzanne A., Fingerhood, Michael, and Stewart, Rosalyn W.
- Published
- 2024
- Full Text
- View/download PDF
3. A pragmatic review of varenicline prescribing practices
- Author
-
Skoloda, Daniel, Dowd-Green, Caitlin, Burdalski, Catherine, Patino, Maika, Weinstein, Sujin, Merrey, Jessica, and Stewart, Rosalyn
- Published
- 2023
- Full Text
- View/download PDF
4. Nutritional Implications of Patients with Dysautonomia and Hypermobility Syndromes
- Author
-
Do, Toan, Diamond, Sarah, Green, Caitlin, and Warren, Malissa
- Published
- 2021
- Full Text
- View/download PDF
5. “The Gluten-Free Diet and Its Relationship with Metabolic Syndrome: Dietary Friend or Foe?”
- Author
-
Dhruva, Vishal, Lawson, Christy, Green, Caitlin, and Newberry, Carolyn
- Published
- 2021
- Full Text
- View/download PDF
6. Fiber in the ICU: Should it Be a Regular Part of Feeding?
- Author
-
Green, Caitlin H., Busch, Rebecca A., and Patel, Jayshil J.
- Published
- 2021
- Full Text
- View/download PDF
7. Postdischarge Evaluation for Individuals Hospitalized with COVID-19
- Author
-
Berkenblit, Gail, O’Connell, Kaelin, Mixter, Sara, Dowd-Green, Caitlin, and Stewart, Rosalyn W.
- Published
- 2022
- Full Text
- View/download PDF
8. Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature
- Author
-
Green, Caitlin H. and Syn, Wing-Kin
- Published
- 2019
- Full Text
- View/download PDF
9. Adapting Interdisciplinary Transitional Ambulatory Practice to Meet the Challenges of COVID-19
- Author
-
Dowd-Green, Caitlin, McLaughlin, Heather, Seymour, Charlotte, Diffenderffer, Chrissy, Bertram, Amanda, and Stewart, Rosalyn W.
- Published
- 2021
- Full Text
- View/download PDF
10. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017
- Author
-
Zika Pregnancy and Infant Registries Working Group, Shapiro-Mendoza, Carrie K., Rice, Marion E., Galang, Romeo R., Fulton, Anna C., VanMaldeghem, Kelley, Prado, Miguel Valencia, Ellis, Esther, Anesi, Magele Scott, Simeone, Regina M., Petersen, Emily E., Ellington, Sascha R., Jones, Abbey M., Williams, Tonya, Reagan-Steiner, Sarah, Perez-Padilla, Janice, Deseda, Carmen C., Beron, Andrew, Tufa, Aifili John, Rosinger, Asher, Roth, Nicole M., Green, Caitlin, Martin, Stacey, Lopez, Camille Delgado, deWilde, Leah, Goodwin, Mary, Pagano, H. Pamela, Mai, Cara T., Gould, Carolyn, Zaki, Sherif, Ferrer, Leishla Nieves, Davis, Michelle S., Lathrop, Eva, Polen, Kara, Cragan, Janet D., Reynolds, Megan, Newsome, Kimberly B., Huertas, Mariam Marcano, Bhatangar, Julu, Quiñones, Alma Martinez, Nahabedian, John F., Adams, Laura, Sharp, Tyler M., Hancock, W. Thane, Rasmussen, Sonja A., Moore, Cynthia A., Jamieson, Denise J., Munoz-Jordan, Jorge L., Garstang, Helentina, Kambui, Afeke, Masao, Carolee, Honein, Margaret A., and Meaney-Delman, Dana
- Published
- 2017
11. Novel Virtual Vision Screening Program: Give Kids Sight Day 2020.
- Author
-
Green, Caitlin P., Lai, Michael J., Gore, Rujuta A., Wu, Connie M., Zhang, Qiang, Sharpe, James E., Elias, Rebecca J., and Wasserman, Barry N.
- Subjects
VISION testing ,EYE examination ,VISUAL acuity ,OUTREACH programs ,CHILD care - Abstract
Purpose: To determine whether a low-technology novel virtual vision screening protocol can reliably screen pediatric visual acuity. Methods: Give Kids Sight Day (GKSD), an annual out-reach program, aims to provide free vision screening and ophthalmic care to underserved children in Philadelphia, Pennsylvania. Children were screened virtually through the low-technology protocol. Based on screening results, 152 children were provided in-person eye examinations. Data from in-person examinations were compared to data from virtual screenings for 151 children who were seen in-person. Results: Of 475 children screened virtually, 152 children were seen in-person for examination, and 151 children were included in the analysis. Results from 151 children (mean age: 10.7 years, age range: 5 to 18 years, 43% female, 28% speaking a non-English language) were reviewed. There was a moderate correlation (R =.64, P <.0001; n = 100 children) between screening and in-person visual acuity without refractive correction and a strong correlation (R = 0.82, P <.0001; n = 18 children) between screening and in-person visual acuity with refractive correction. Of the 140 children who were seen in-person, 133 children were provided glasses prescriptions. Seventeen children required a referral to a pediatric ophthalmologist for evaluation of ophthalmic conditions, most commonly strabismus (5.3%) and amblyopia (4%). Conclusions: The GKSD virtual visual acuity testing demonstrated good correlation with in-person visual acuity testing, supporting the virtual screening approach as a useful tool for future applications in widespread community vision outreach programs. Further studies are needed to refine virtual ophthalmic screening to optimize its applications in bridging the gaps in ophthalmic care. [J Pediatr Ophthalmol Strabismus. 2023;60(6):390–395.] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network
- Author
-
Lathrop, Eva, Hurst, Stacey, Mendoza, Zipatly, Zapata, Lauren B., Cordero, Pierina, Powell, Rachel, Green, Caitlin, Moreno, Nilda, Jamieson, Denise J., and Romero, Lisa
- Published
- 2020
- Full Text
- View/download PDF
13. Nutrition in Cirrhosis
- Author
-
Palmer, Lena B., Kuftinec, Gabriela, Pearlman, Michelle, and Green, Caitlin Homberger
- Published
- 2019
- Full Text
- View/download PDF
14. Screening and Brief Interventions for Alcohol Use During Pregnancy: Practices Among US Primary Care Clinicians, DocStyles 2019.
- Author
-
Green, Caitlin, George, Nisha, Youngjoo Park, Denny, Clark H., Weber, Mary Kate, Meaney-Delman, Dana, and Kim, Shin Y.
- Published
- 2023
- Full Text
- View/download PDF
15. Community Perspectives on Contraception in the Context of Zika Virus in American Samoa and the Commonwealth of the Northern Mariana Islands.
- Author
-
Romero, Lisa, Powell, Rachel, Ntansah, Charity, Bednar, Hailey, Green, Caitlin, Brittain, Anna, Torrez, Ruben, Barrineau, Irene, Pangelinan, Heather S., Timoteo-Liaina, Ianeta, Garcia, Luis, and Lathrop, Eva
- Subjects
ZIKA virus ,CONTRACEPTION ,COMMUNITIES ,BIRTH control ,FAMILY planning - Abstract
The prevention of unintended pregnancy was identified as a primary prevention strategy to reduce Zika-related adverse birth outcomes during the 2016-2017 Zika virus outbreak. The Centers for Disease Control and Prevention in partnership with local health agencies conducted formative research to guide the development of culturally appropriate messages and materials to increase awareness of the prevention of unintended pregnancy as a strategy to decrease Zika-related adverse outcomes in American Samoa and the Commonwealth of the Northern Mariana Islands (CNMI). Nine focus groups (N=71) were conducted with women and men aged 18-44 years living in American Samoa and CNMI. Semi-structured interview guides were used to explore participants' knowledge and perceptions of Zika, family planning, and contraception; barriers and facilitators to access contraception and use; and information sources and contraception decision-making. Trained staff from local organizations co-moderated each focus group. Thematic analysis was conducted with NVivo 10. Participants had mixed knowledge about Zika virus and its relation to pregnancy and birth defects. Women and men had varied knowledge of the full range of contraceptive methods available in their jurisdiction and identified barriers to contraceptive access. Social factors including stigma, gender roles, and religion often deterred participants from accessing contraceptive services. Participants highlighted the need for culturally appropriate and clear messaging about contraceptive methods. Results demonstrate the feasibility of conducting formative research as an effective strategy for understanding community perspectives on unintended pregnancy prevention in the context of the Zika virus outbreak to develop health communication materials. [ABSTRACT FROM AUTHOR]
- Published
- 2022
16. P221: Attitudes and Barriers Regarding Mpox Vaccine Among Unvaccinated Men Who Have Sex with Men.
- Author
-
Green, Caitlin J., Finley, Elizabeth H., Hall, Grace, Kachur, Rachel, McLeod, Timothy, and Merritt, Matthew L.
- Abstract
Background: The 2022 mpox outbreak has disproportionately affected gay, bisexual, and other men who have sex with men (MSM). Vaccination is an important tool in preventing the spread of mpox. The Centers for Disease Control and Prevention (CDC) recommends JYNNEOS vaccination for people at high risk for mpox infection. To better understand reasons for not getting the mpox vaccine, the National Coalition of STD Directors (NCSD) and CDC conducted a virtual focus group with unvaccinated MSM who are at-risk for mpox. Methods: In October and November 2022, MSM were recruited through online panels to participate in a virtual 60-minute, moderated focus group within an artificial intelligence (AI) platform. Participants were asked open- and closed-ended questions through a chat-based conversation. The AI platform used machine learning and natural language processing to immediately analyze participants' responses and provide results instantly to the moderator. After the session, descriptive frequencies, cross-tabulations and qualitative themes were analyzed. Results: Fifty-one MSM participated, of whom 39% reported wanting the mpox vaccine but 76% had never tried to get it. When participants were asked if they would get the vaccine if it were available to them right now, 55% reported they would, with similar proportions of white (55%), Black (50%), and Latino/Hispanic (44%) men answering affirmatively. Concerns about getting vaccinated included injection site scarring (31%), rashes (29%), or fear of healthcare provider stigmatization (27%). The top three barriers experienced when trying to get the vaccine included: challenges in scheduling appointments (33%), finding available vaccine locations (25%), and transportation issues (17%). Among the participants who want the vaccine, 70% considered themselves to be at high or medium risk of contracting mpox. Conclusion: Gay, bisexual, and other MSM experience barriers in accessing the mpox vaccine, a vital prevention tool to averting another outbreak. Messaging about vaccine effectiveness, potential side effects, and how to access the vaccine may improve vaccine uptake. Improving healthcare provider cultural competency, expanding vaccine availability, and establishing non-traditional vaccination programs such as at pop-up events may also improve uptake. [ABSTRACT FROM AUTHOR]
- Published
- 2024
17. School Shootings: International Research, Case Studies, and Concepts for Prevention: Nils Bockler, Thorsten Seeger, Peter Sitzer, Wilhelm Heitmyer, Editors, Springer Science + Business Media New York, 2013. 543 Pages. $144.01
- Author
-
Green, Caitlin R.
- Published
- 2017
- Full Text
- View/download PDF
18. Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report.
- Author
-
Dowd-Green, Caitlin, Brown, Dannielle, Wilson, Alexandra, and Streiff, Michael
- Abstract
Background : Several studies have examined INR fluctuations using pharmacokinetic (PK) models or post-hoc INR values after completing nirmatrelvir/ritonavir, but further study of the effects of the drug interaction with warfarin during treatment is necessary.Case Summary : Nirmatrelvir/ritonavir is largely utilized in the outpatient setting so data regarding INR trends in hospitalized patients on warfarin is limited. However, many who receive nirmatrelvir/ritonavir outpatient experience difficulty with presenting to clinic for INR checks due to feeling acutely ill along with isolation precautions. We present the case of a patient receiving warfarin and utilizing home INR testing for monitoring. After diagnosis of coronavirus disease of 2019 (COVID-19), she was started on nirmatrelvir/ritonavir on day five after testing positive. Most recent INR prior to the start of therapy was 2.7 and had been stable on the same dose for months prior to infection. On day two of nirmatrelvir/ritonavir, her INR rose to 4.0 on home point of care INR testing. Despite reducing her dose of warfarin by 15%, her INR remained supratherapeutic the day after completing nirmatrelvir/ritonavir (4.0) and for several checks after. One month after completion of therapy, her INR returned to therapeutic levels.Practice Implications : While PK models and case series have hypothesized both potential increases or decreases in INR with the nirmatrelvir/ritonavir and warfarin interaction, COVID-19 infection itself can cause several pharmacodynamic changes which can increase INR, including decreased appetite and, in severe cases, organ dysfunction. This case provides real-world insight into the drug interaction between nirmatrelvir/ritonavir and the drug-disease state interaction between warfarin and COVID-19. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
19. Comparing mean and single automated office blood pressure measurement in a US ambulatory care setting.
- Author
-
Buettner, Tammy, Bertram, Amanda, Floyd, Olivia, Dowd-Green, Caitlin, and Stewart, Rosalyn
- Subjects
KRUSKAL-Wallis Test ,RESEARCH evaluation ,MANN Whitney U Test ,COMPARATIVE studies ,T-test (Statistics) ,AMBULATORY blood pressure monitoring ,QUALITY assurance ,DESCRIPTIVE statistics ,CHI-squared test ,BLOOD pressure measurement ,DATA analysis software ,LONGITUDINAL method - Abstract
Accurate blood pressure measurement is essential to appropriately diagnose and treat hypertension. Blood pressure is usually measured by taking a single automated office blood pressure (AOBP) reading, but there are newer, fully automated devices that calculate the mean of several blood pressure readings. A quality improvement initiative was conducted in a US ambulatory care setting to determine whether there were differences in the accuracy of blood pressure measurement when measuring mean AOBP versus single AOBP. A population of 126 patients attending a transitional care clinic at an urban hospital were randomly assigned to receive mean AOBP measurement at the beginning of their appointment, at the end of their appointment, or not at all. This randomised prospective evaluation did not find conclusive evidence regarding the use of mean AOBP measurement versus single AOBP measurement. However, using a fully automated device that calculates mean AOBP may be useful in busy clinical settings, allowing nurses to spend more time on other aspects of their role such as patient education and care coordination. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Communication experiences of healthcare students whilst managing adults with communication disorders.
- Author
-
Rathiram, Vrinda, Neilson, Lauren O., Kassim, Azraa Syed, Mokone, Winnie T., and Green, Caitlin C.
- Published
- 2022
- Full Text
- View/download PDF
21. Measuring the contribution of clinical rotations to skills confidence in primary care nurse practitioner students.
- Author
-
MacDonald, Brent, Floyd, Olivia, Dowd-Green, Caitlin, Bertram, Amanda, Fingerhood, Marianne, Sharps, Phyllis, and Stewart, Rosalyn W.
- Subjects
CONFIDENCE ,NURSING ,SELF-evaluation ,HUMAN comfort ,MOTIVATIONAL interviewing ,MEDICAL care ,PRIMARY health care ,INTERNSHIP programs ,SURVEYS ,PRE-tests & post-tests ,DIAGNOSTIC imaging ,DESCRIPTIVE statistics ,ELECTROCARDIOGRAPHY ,NURSING students ,METROPOLITAN areas ,DATA analysis software ,CURRICULUM planning - Abstract
Primary care providers (PCPs) are essential components of a health care system, but there are shortages of PCPs. Nurse practitioners (NPs) are essential in meeting the needs of an increased demand for primary care, but there is a wide variety in the training offered to NP students. The purpose of this analysis is to determine student self-reported comfort in a variety of care delivery, covering primary care topics, including knowledge and skills. We conducted a preclinical and postclinical survey. Surveys were obtained before and at the conclusion of two clinical rotations in Baltimore, MD. Students were a part of a Health Resources and Services Administration–funded program to prepare NP students to practice in urban, underserved settings. Seventeen NP students NP students responded to both our pre- and postsurveys. Overall, student comfort increased in many focus areas, but no change was seen in important domains, including interpreting imaging studies, filling out common forms, and interpreting certain diagnostic tests. Further study of student skills and confidence at the conclusion of their study would be beneficial in determining if these gaps persist at entry into NP practice. Given wide variation in NP student training programs, it would be additionally beneficial to understand how these differences impact student skills and confidence during their clinical rotations and on entry to practice. Well rounded, broad-based education is necessary for the development of highly trained PCPs; greater understanding of student confidence, knowledge, and skills can assist educators in assuring that all NPs enter practice as safe and competent providers. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. A Case for Comprehensive Transitional Care for Formerly Incarcerated Individuals.
- Author
-
Rasmussen, Patrick, Bertram, Amanda, Dowd-Green, Caitlin, and Stewart, Rosalyn W.
- Subjects
EVALUATION of medical care ,SOCIAL determinants of health ,PRISONERS ,TRANSITIONAL care ,MEDICAL care of prisoners ,ADVERSE health care events ,NEED (Psychology) - Abstract
People released from prison are at risk of adverse health outcomes in the weeks after release. This article describes cases that illustrate the complexity of caring for this population. It is important to address medical and psychological needs as well as factors that contribute to social determinants of health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Does an encounter with the ambulatory clinical pharmacist in the transitional setting play a role in clinic attendance and patient engagement?
- Author
-
Smith, Kristi, Dowd-Green, Caitlin, Emerson, Ally, Bertram, Amanda, and Stewart, Rosalyn
- Subjects
HEALTH care teams ,SAFETY-net health care providers ,PHARMACISTS ,PATIENT aftercare ,PATIENT participation ,HOSPITAL pharmacies ,DISCHARGE planning - Abstract
Background: Patient engagement is an important aspect in improving patient outcomes. However, there is a paucity of literature regarding patient engagement in a nonresearch health care setting and the impacts of ambulatory clinical pharmacist interventions. Patient engagement has several definitions making it challenging to assess, but attendance to initial primary care provider (PCP) visits is an important aspect of patient engagement.Objective: The study objective was to assess if improved patient engagement, defined as attendance to an initial PCP visit, was associated with differences in services provided or pharmacist participation during postdischarge clinic appointments.Practice Description: The site of this study was the Johns Hopkins After Care Clinic (JHACC), an interdisciplinary postdischarge, safety net clinic in Baltimore, MD.Practice Innovation: Through an interdisciplinary health care team including pharmacists, patients received comprehensive care to assist with postacute disease-state management and transitions of care.Evaluation Methods: Initial PCP visit attendance after a postacute visit in a high-risk population was evaluated for differing service delivery factors between groups who attended and did not attend their initial PCP visit. Descriptive statistics and chi-square tests were used for analysis.Results: Patients were statistically significantly more likely to engage in primary care when clinical pharmacy specialists participated in their JHACC appointment (P = 0.02). Medication education and disease-state counseling improved initial PCP visit attendance, both of which are key pharmacist activities.Conclusion: This study suggests ambulatory clinical pharmacy specialists' roles in an interdisciplinary clinic model correlates with increased attendance to initial PCP visits, a surrogate for patient engagement. Disease-state education and medication education are both important activities in improving this measure; however, additional research is necessary to determine specific pharmacist interventions associated with patient engagement. As research in patient engagement continues, the positive effects of pharmacist involvement in this area could support their value in ambulatory care services. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
24. Letter to the Editor: Adapting Interdisciplinary Transitional Ambulatory Practice to Meet the Challenges of COVID-19.
- Author
-
Dowd-Green, Caitlin, McLaughlin, Heather, Seymour, Charlotte, Diffenderffer, Chrissy, Bertram, Amanda, and Stewart, Rosalyn W.
- Subjects
PHYSIOLOGICAL adaptation ,OUTPATIENT medical care ,HEALTH care teams ,INTEGRATED health care delivery ,INTERPROFESSIONAL relations ,MEDICAL care ,PATIENT satisfaction ,TELEMEDICINE ,HEALTH & social status ,SOCIAL distancing ,COVID-19 pandemic - Abstract
COVID-19 restructured the health care delivery process, catapulting telemedicine to the mainstream. The Johns Hopkins After Care Clinic (JHACC) continued transprofessional health care delivery in the telemedicine space by shifting to remote, asynchronous collaboration and a triage system. In 1 month after starting telemedicine, the JHACC had 907 encounters for 376 unique patients. Most patients reported satisfaction with their visits. Telemedicine lengthened visit completion times. Providers encountered many failed call attempts and limited access to videoconferencing. Barriers to sustainable interprofessional telemedicine include poor social determinants of health, limited reimbursement for nonphysician health professionals, and increased clinical and administrative time. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.
- Author
-
Tran, Emmy L., Kim, Shin Y., England, Lucinda J., Green, Caitlin, Dang, Elizabeth P., Broussard, Cheryl S., Fehrenbach, Nicole, Hudson, Amy, Yowe-Conley, Tineka, Gilboa, Suzanne M., and Meaney-Delman, Dana
- Subjects
METHADONE treatment programs ,SUBSTANCE abuse treatment ,BEHAVIOR therapy ,BUPRENORPHINE ,CHILD health services ,HERBAL medicine ,NARCOTIC antagonists ,NARCOTICS ,HEALTH outcome assessment ,PUBLIC health surveillance ,TREATMENT effectiveness ,PREGNANCY outcomes ,PREGNANCY - Abstract
Pregnant women with opioid use disorder (OUD) are at risk of overdose, infectious diseases, and inadequate prenatal care. Additional risks include adverse pregnancy and infant outcomes, such as preterm birth and neonatal abstinence syndrome. Management and treatment of OUD during pregnancy are associated with improved maternal and infant outcomes. Professional organizations, including the American College of Obstetricians and Gynecologists, recommend offering opioid agonist pharmacotherapy (i.e., methadone or buprenorphine) combined with behavioral therapy as standard treatment for pregnant women with OUD. Other medications and herbal supplements have also been used by pregnant women for OUD. Determining which OUD treatments optimize maternal and infant outcomes is challenging given the host of potential factors that affect these outcomes. The Centers for Disease Control and Prevention initiated the MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder during Pregnancy (MAT-LINK) to monitor more than 2000 mothers and their infants, using data collected from geographically diverse clinical sites. Information learned from MAT-LINK will inform the future management and treatment of pregnant women with OUD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons.
- Author
-
Shimabukuro, Tom T., Kim, Shin Y., Myers, Tanya R., Moro, Pedro L., Oduyebo, Titilope, Panagiotakopoulos, Lakshmi, Marquez, Paige L., Olson, Christine K., Liu, Ruiling, Chang, Karen T., Ellington, Sascha R., Burkel, Veronica K., Smoots, Ashley N., Green, Caitlin J., Licata, Charles, Zhang, Bicheng C., Alimchandani, Meghna, Mba-Jonas, Adamma, Martin, Stacey W., and Gee, Julianne M.
- Published
- 2021
- Full Text
- View/download PDF
27. Unintentional use of fentanyl attributed to surreptitious cannabis adulteration.
- Author
-
Hopwood, Taylor, Dowd-Green, Caitlin, Mason, Melissa, and Stewart, Rosalyn W.
- Subjects
MARIJUANA ,OPIOID abuse ,FENTANYL ,ADULTERATIONS ,SUBSTANCE-induced disorders ,SUBSTANCE abuse ,BUPRENORPHINE - Abstract
Objective: This case addresses the issue of surreptitious adulteration of cannabis. Many with opioid and substance use disorders use cannabis while receiving office-based opioid treatment (OBOT), making it valuable to understand the rationale for its use. Further study of the effects that cannabis use has on OBOT success or failure is necessary.Case Summary: A 50-year-old man receiving OBOT continually tested positive in urine drug screenings (UDSs) for fentanyl, while abstaining from all opiates, but he endorsed smoking cannabis 2-3 times weekly as a self-reported headache reliever and a sleep aid. After changing the source from which he bought cannabis, his UDS became negative for fentanyl. He was maintained on a stable dose of buprenorphine with a consistent UDS after this intervention and was able to make many positive lifestyle changes as a result (i.e., maintaining a relationship with his girlfriend, continuing attendance at support groups, and pursuing employment opportunities).Practice Implications: The consequences of cannabis use on OBOT success are highly variable and dependent on many factors. Although the concern regarding adulteration of cannabis exists, there is no systematic monitoring or reliable data on its frequency or the magnitude of its effect, which generates a demand for further research and exploration. Depending on state-specific regulations, patients may be able to obtain cannabis from reliable, regulated (nonadulterated) sources. However, providers must thoroughly consider the barriers to patients obtaining medicinal or legalized cannabis. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
28. Assessment of Contraceptive Needs and Improving Access in the U.S.-Affiliated Pacific Islands in the Context of Zika.
- Author
-
Green, Caitlin, Ntansah, Charity, Frey, Meghan T., Krashin, Jamie W., Lathrop, Eva, and Romero, Lisa
- Subjects
- *
CONTRACEPTION laws , *CIVIL defense , *HEALTH services accessibility , *EVALUATION of medical care , *MEDICAL needs assessment , *MOSQUITO vectors , *PREGNANCY , *UNPLANNED pregnancy , *FAMILY planning , *ZIKA virus infections , *INFECTIOUS disease transmission - Abstract
Scientific evidence demonstrated a causal relationship between Zika virus infection during pregnancy and neurologic abnormalities and other congenital defects. The U.S. government's Zika Virus Disease Contingency Response Plan recognized the importance of preventing unintended pregnancy through access to high-quality family planning services as a primary strategy to reduce adverse Zika-related birth outcomes during the 2016–2017 Zika virus outbreak. The U.S.-affiliated Pacific Islands (USAPI) includes three U.S. territories: American Samoa, the Commonwealth of the Northern Mariana Islands, and Guam, and three independent countries in free association with the United States: the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Aedes spp. mosquitoes, the primary vector that transmits Zika virus, are common across the Pacific Islands, and in 2016, laboratory-confirmed cases of Zika virus infection in USAPI were reported. CDC conducted a rapid assessment by reviewing available reproductive health data and discussing access to contraception with family planning providers and program staff in all six USAPI jurisdictions between January and May 2017. In this report, we summarize findings from the assessment; discuss strategies developed by jurisdictions to respond to identified needs; and describe a training that was convened to provide technical assistance to USAPI. Similar rapid assessments may be used to identify training and technical assistance needs in other emergency preparedness and response efforts that pose a risk to pregnant women and their infants. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
29. A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation in a Tertiary Eye Care Center.
- Author
-
Mayro, Eileen L., Pizzi, Laura T., Hark, Lisa A., Murchison, Ann P., Wisner, Douglas, Koka, Anish, Leiby, Benjamin E., Dabbish, Nooreen, Okulate, Adedoyin, BS, Dessy, Alexa, Green, Caitlin, and Bailey, Robert
- Abstract
BACKGROUND: Cataracts are the leading cause of preventable blindness globally. As a result, competence in cataract surgery is an important component of ophthalmology residency training. Residency programs must optimize the number of cataract surgery cases to train proficient physicians. However, the rate of cataract surgery cancellations is high, and some are canceled because of preventable causes. OBJECTIVE: To evaluate the effect of mandatory on-site preadmission testing, including having a physical examination, on resident-performed cataract surgery cancellation rates. METHODS: For this study, patients scheduled for cataract surgery at the Wills Eye Hospital resident cataract clinic between January 2015 and November 2015 were enrolled and randomized into 2 groups: usual care or intervention. The patients randomized to the usual care group were instructed to complete preadmission testing and to have a physical examination with their primary care physician. The patients randomized to the intervention group were escorted to a Wills Eye Hospital-affiliated cardiologist to complete preadmission testing and to have a physical examination. Patients in both groups received a reminder call before the cataract surgery. RESULTS: A total of 441 patients were included in the study-240 patients in the usual care group and 201 patients in the intervention group. The overall cataract surgery cancellation rate was 14.5%; the rate was 12.4% in the intervention group and 16.3% in the usual care group (P = .28). The patients receiving the intervention were more likely to have preadmission testing and a physical examination than the patients in the usual care arm (P <.001). CONCLUSIONS: Facilitating the completion of preadmission testing for patients decreased the rates of resident-performed cataract surgery cancellation at a Wills Eye Hospital resident clinic and has the potential to improve patient outcomes and prevent blindness. [ABSTRACT FROM AUTHOR]
- Published
- 2018
30. Using the aftercare clinic as an interdisciplinary bridge to longitudinal care.
- Author
-
Dowd-Green, Caitlin, Merrey, Jessica W., and Stewart, Rosalyn W.
- Subjects
- *
COST control , *HEALTH facility administration , *PATIENT aftercare , *PHARMACISTS , *URBAN hospitals , *PATIENT readmissions - Abstract
The article looks at the Johns Hopkins After Care Clinic (JHACC) as the first service to incorporate pharmacists into an interdisciplinary post-emergency department or post-hospitalization safety net clinic setting. Topics mentioned include the goal of JHACC to lower use of emergency services, care provided by JHACC for at-risk patients, and the primary outcomes used to measure JHACC's success and financial viability.
- Published
- 2017
- Full Text
- View/download PDF
31. Assessment of the Standardized Surveillance Case Definition for Neonatal Abstinence Syndrome by the Council of State and Territorial Epidemiologists, 4 Jurisdictions, 2020-2021.
- Author
-
Czarnik, Michaila, Oliver, Darielle, Goodson, Valerie, Nestoridi, Eirini, Michael Bryan, J., Hinds, Deborah, Clark, Carolina, Green, Caitlin, Small, James, and Pabst, Laura
- Abstract
In 2019, the Council of State and Territorial Epidemiologists ratified a multitiered standardized surveillance case definition (SSCD) for neonatal abstinence syndrome (NAS) to minimize variability in definitions across states. This evaluation of the tier 1 NAS SSCD aimed to identify common challenges and opportunities for enhancement to support consistent implementation of the definition.This mixed-methods analysis consisted of 3 virtual focus groups in March 2021 with site principal investigators, medical record abstractors, and data analysts (1 focus group each) from 4 jurisdictions piloting the tier 1 NAS SSCD. We analyzed focus group transcripts to create a codebook. We collected written reports in February 2022 from the 4 jurisdictions, conducted thematic analysis of focus group transcripts and written reports to identify themes, and collected surveillance data on infants identified with NAS born from January 2020 through December 2021 from the pilot sites. We analyzed surveillance data to further inform identified themes. We examined agreement among tier 1 classifications assigned independently by each pilot site and the Centers for Disease Control and Prevention to cases of NAS.Three major themes emerged in the data: challenges abstracting data on withdrawal signs from the medical record, difficulty determining the time frame of prenatal substance exposure, and challenges assigning case classifications. In a comparison of tier 1 classifications assigned by the Centers for Disease Control and Prevention and the sites, 82.1% of cases in the dataset were concordant.We identified several opportunities to modify the SSCD to promote consistency and ease implementation across jurisdictions. Promoting consistent implementation supports comparability of NAS incidence estimates across jurisdictions, evaluation of prevention efforts, and allocation of resources to support families. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Institutional practices for charitable medication access for uninsured patients.
- Author
-
Kumar A, Dowd-Green C, Green R, and Stewart R
- Subjects
- Humans, Retrospective Studies, Medically Uninsured, Institutional Practice, Drug Prescriptions, Diabetes Mellitus, Pharmacies
- Abstract
Objectives: To identify the most frequently prescribed medications, the location where prescriptions were filled, and whether a voucher was utilized among patients enrolled in a charitable care program within an academic medical center., Study Design: This was a retrospective cohort study analyzing electronic health record and pharmacy dispensing information at a medical center's outpatient pharmacies., Methods: Patients included in this analysis were enrolled in a charitable care program and had at least 1 ambulatory encounter in a primary care clinic from March 1, 2019, to June 30, 2021. The study identified frequently prescribed medications, prescription payment methods, the overall cost of prescriptions if available, and the percentage of patients who filled their prescription at a medical center's outpatient pharmacies vs external outpatient pharmacies. Descriptive statistics were used to describe the results., Results: This study included 511 patients, 87% of whom were Spanish speaking. A total of 8453 prescriptions were identified, and more than half of the prescriptions were sent to external outpatient pharmacies. The most common medications prescribed were for cardiovascular disease, diabetes, and pain treatment. Forty-seven percent of all prescriptions were sent to the medical center's outpatient pharmacies. The medical center's charitable care program covered the costs of 44% of the prescriptions sent to internal pharmacies, assisting 148 unique patients and incurring a cost of $111,052 for the medical center., Conclusions: Overall, this study was able to characterize patient demographics, historical costs related to charitable care coverage, and the utilization of health care services among this population. This information can be used to support the development and implementation of a charitable medication formulary, with the aims of improving quality of care for this population and reducing medical center costs.
- Published
- 2024
- Full Text
- View/download PDF
33. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
- Author
-
Miele K, Kim SY, Jones R, Rembert JH, Wachman EM, Shrestha H, Henninger ML, Kimes TM, Schneider PD, Sivaloganathan V, Sward KA, Deshmukh VG, Sanjuan PM, Maxwell JR, Seligman NS, Caveglia S, Louis JM, Wright T, Bennett CC, Green C, George N, Gosdin L, Tran EL, Meaney-Delman D, and Gilboa SM
- Subjects
- Adult, Female, Humans, Infant, Pregnancy, Ethnicity statistics & numerical data, Family, Hispanic or Latino statistics & numerical data, United States epidemiology, Pregnancy Outcome, Young Adult, Black or African American statistics & numerical data, White statistics & numerical data, Opioid-Related Disorders drug therapy, Opioid-Related Disorders epidemiology, Opioid-Related Disorders ethnology, Population Surveillance methods
- Abstract
Problem: Medication for opioid use disorder (MOUD) is recommended for persons with opioid use disorder (OUD) during pregnancy. However, knowledge gaps exist about best practices for management of OUD during pregnancy and these data are needed to guide clinical care., Period Covered: 2014-2021., Description of the System: Established in 2019, the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy (MAT-LINK) is a surveillance network of seven clinical sites in the United States. Boston Medical Center, Kaiser Permanente Northwest, The Ohio State University, and the University of Utah were the initial clinical sites in 2019. In 2021, three clinical sites were added to the network (the University of New Mexico, the University of Rochester, and the University of South Florida). Persons receiving care at the seven clinical sites are diverse in terms of geography, urbanicity, race and ethnicity, insurance coverage, and type of MOUD received. The goal of MAT-LINK is to capture demographic and clinical information about persons with OUD during pregnancy to better understand the effect of MOUD on outcomes and, ultimately, provide information for clinical care and public health interventions for this population. MAT-LINK maintains strict confidentiality through robust information technology architecture. MAT-LINK surveillance methods, population characteristics, and evaluation findings are described in this inaugural surveillance report. This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023., Results: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014-2021 among persons with OUD from seven clinical sites. The mean maternal age was 29.7 (SD = ±5.1) years. By race and ethnicity, 86.3% of pregnant persons were identified as White, 25.4% as Hispanic or Latino, and 5.8% as Black or African American. Among pregnant persons, 81.6% had public insurance, and 84.4% lived in urban areas. Compared with persons not receiving MOUD during pregnancy, those receiving MOUD during pregnancy were more likely to be older and White and to have public insurance. The evaluation of the surveillance system found that the initial four clinical sites were not representative of demographics of the South or Southwest regions of the United States and had low representation from certain racial and ethnic groups compared with the overall U.S. population; however, the addition of three clinical sites in 2021 made the surveillance network more representative. Automated extraction and processing improved the speed of data collection and analysis. The ability to add new clinical sites and variables demonstrated the flexibility of MAT-LINK., Interpretation: MAT-LINK is the first surveillance system to collect comprehensive, longitudinal data on pregnant person-infant dyads with perinatal outcomes associated with MOUD during pregnancy from multiple clinical sites. Analyses of clinical site data demonstrated different sociodemographic characteristics between the MOUD and non-MOUD treatment groups., Public Health Actions: MAT-LINK is a timely and flexible surveillance system with data on approximately 5,500 pregnancies. Ongoing data collection and analyses of these data will provide information to support clinical and public health guidance to improve health outcomes among pregnant persons with OUD and their children., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. The Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy (MAT-LINK) is funded by the Assistant Secretary for Planning and Evaluation’s Office of the Secretary Patient-Centered Outcomes Research Trust Fund. All clinical site coauthors report funding for MAT-LINK. Katherine A. Sward reports funding from the National Institutes of Health for work with the Helping to End Addiction Long-Term (HEAL) Pain Management Effectiveness Research Network as a Data Coordinating Center. Vikrant G. Deshmukh reports a National Cancer Institute/University of Wisconsin subaward for investigating COVID-19 complications among smokers. Pilar M. Sanjuan reports funding as a principal investigator from the National Institute on Alcohol Abuse and Alcoholism for Project REACT (neural underpinnings of emotional regulation and drinking to cope); the National Institute on Drug Abuse for Project Vida (prenatal opioid use disorder and posttraumatic stress disorder); and the National Institute of Mental Health for Project Raptor (attention and post-traumatic stress disorder) and as a coinvestigator from the National Institute on Alcohol Abuse and Alcoholism on Project AsCENd (neuroimaging of child attention development); the National Institute on Drug Abuse Helping to End Addiction Long-Term initiative for Integrative Management of chronic Pain and OUD for Whole Recovery (pain and prenatal opioid use) and for the HEALthy Brain and Child Development study; and relationships with New Mexico Postpartum Support International as a board chair and the New Mexico Perinatal Collaborative as a board member. Jessie R. Maxwell reports funding from the National Institute on Drug Abuse for work as a coinvestigator on the HEALthy Brain and Childhood Development studies; the National Institutes of Health for work as a Helping to End Addiction Long-Term initiative alternate principal investigator; the National Institute on Alcohol Abuse and Alcoholism for work as a principal investigator on a project; the National Institute on Alcohol Abuse and Alcoholism for work as a coinvestigator on a local project; and the IDeA States Pediatric Clinical Trials Network for work as site principal investigator, work as a junior investigator, and meeting attendance as a member of the leadership committee. Neil S. Seligman reports funding from PreTel Inc. and Mae Stone Goode for work not related to this report; Natera for consulting fees; UpToDate for writing; and various legal reviews. Judette Louis reports funding from TD Bank for an institutional grant; Wolters Kluwer for an UpToDate piece on sleep apnea during pregnancy; Hologic for a one-time fee; Elsevier for serving as a textbook editor; Goldasich, Vick & Fulk for a fee; Sleep Disorder Research Advisory Board for being a member; the National Institutes of Health for work on a personalized integrated chronotherapy for perinatal depression; March of Dimes for travel expenses related to being a board member; Society for Maternal-Fetal Medicine for travel expenses related to being a board member; American Board of Obstetrics and Gynecology for travel expenses related to being a board member; and Preeclampsia Foundation for blood pressure cuffs for her institution. Tanner Wright reports funding from Duke University for a National Institutes of Health–funded project on Eating, Sleeping, Consoling for Neonatal Opioid Withdrawal Syndrome (ESC-NOW): a Function-Based Assessment and Management Approach; the National Institute on Drug Abuse for CADENCE (Continuous and Data-driven Care); the American Academy of Pediatrics for work as a subject matter expert on maternal–infant health and opioid use; and the National Advanced Practice and Low Risk Neonatal Nurses Conferences for presentations on neonatal opioid withdrawal syndrome. No other potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
34. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
- Author
-
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, Marquez PL, Olson CK, Liu R, Chang KT, Ellington SR, Burkel VK, Smoots AN, Green CJ, Licata C, Zhang BC, Alimchandani M, Mba-Jonas A, Martin SW, Gee JM, and Meaney-Delman DM
- Subjects
- Abortion, Spontaneous epidemiology, Adolescent, Adult, Adverse Drug Reaction Reporting Systems, COVID-19 Vaccines immunology, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Middle Aged, Premature Birth epidemiology, Public Health Surveillance methods, Registries, United States epidemiology, Vaccines, Synthetic adverse effects, Young Adult, mRNA Vaccines, COVID-19 Vaccines adverse effects, Pregnancy
- Abstract
Background: Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy., Methods: From December 14, 2020, to February 28, 2021, we used data from the "v-safe after vaccination health checker" surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS) to characterize the initial safety of mRNA Covid-19 vaccines in pregnant persons., Results: A total of 35,691 v-safe participants 16 to 54 years of age identified as pregnant. Injection-site pain was reported more frequently among pregnant persons than among nonpregnant women, whereas headache, myalgia, chills, and fever were reported less frequently. Among 3958 participants enrolled in the v-safe pregnancy registry, 827 had a completed pregnancy, of which 115 (13.9%) resulted in a pregnancy loss and 712 (86.1%) resulted in a live birth (mostly among participants with vaccination in the third trimester). Adverse neonatal outcomes included preterm birth (in 9.4%) and small size for gestational age (in 3.2%); no neonatal deaths were reported. Although not directly comparable, calculated proportions of adverse pregnancy and neonatal outcomes in persons vaccinated against Covid-19 who had a completed pregnancy were similar to incidences reported in studies involving pregnant women that were conducted before the Covid-19 pandemic. Among 221 pregnancy-related adverse events reported to the VAERS, the most frequently reported event was spontaneous abortion (46 cases)., Conclusions: Preliminary findings did not show obvious safety signals among pregnant persons who received mRNA Covid-19 vaccines. However, more longitudinal follow-up, including follow-up of large numbers of women vaccinated earlier in pregnancy, is necessary to inform maternal, pregnancy, and infant outcomes., (Copyright © 2021 Massachusetts Medical Society.)
- Published
- 2021
- Full Text
- View/download PDF
35. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.
- Author
-
Shapiro-Mendoza CK, Rice ME, Galang RR, Fulton AC, VanMaldeghem K, Prado MV, Ellis E, Anesi MS, Simeone RM, Petersen EE, Ellington SR, Jones AM, Williams T, Reagan-Steiner S, Perez-Padilla J, Deseda CC, Beron A, Tufa AJ, Rosinger A, Roth NM, Green C, Martin S, Lopez CD, deWilde L, Goodwin M, Pagano HP, Mai CT, Gould C, Zaki S, Ferrer LN, Davis MS, Lathrop E, Polen K, Cragan JD, Reynolds M, Newsome KB, Huertas MM, Bhatangar J, Quiñones AM, Nahabedian JF, Adams L, Sharp TM, Hancock WT, Rasmussen SA, Moore CA, Jamieson DJ, Munoz-Jordan JL, Garstang H, Kambui A, Masao C, Honein MA, and Meaney-Delman D
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, United States epidemiology, Pregnancy Complications, Infectious epidemiology, Pregnancy Outcome, Zika Virus Infection epidemiology
- Abstract
Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for Zika virus infection, which can lead to severe fetal and infant brain abnormalities and microcephaly (1). In February 2016, CDC recommended 1) routine testing for Zika virus infection of asymptomatic pregnant women living in areas with ongoing local Zika virus transmission at the first prenatal care visit, 2) retesting during the second trimester for women who initially test negative, and 3) testing of pregnant women with signs or symptoms consistent with Zika virus disease (e.g., fever, rash, arthralgia, or conjunctivitis) at any time during pregnancy (2). To collect information about pregnant women with laboratory evidence of recent possible Zika virus infection* and outcomes in their fetuses and infants, CDC established pregnancy and infant registries (3). During January 1, 2016-April 25, 2017, U.S. territories
† with local transmission of Zika virus reported 2,549 completed pregnancies§ (live births and pregnancy losses at any gestational age) with laboratory evidence of recent possible Zika virus infection; 5% of fetuses or infants resulting from these pregnancies had birth defects potentially associated with Zika virus infection¶ (4,5). Among completed pregnancies with positive nucleic acid tests confirming Zika infection identified in the first, second, and third trimesters, the percentage of fetuses or infants with possible Zika-associated birth defects was 8%, 5%, and 4%, respectively. Among liveborn infants, 59% had Zika laboratory testing results reported to the pregnancy and infant registries. Identification and follow-up of infants born to women with laboratory evidence of recent possible Zika virus infection during pregnancy permits timely and appropriate clinical intervention services (6).- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.